Alpine Immune Sciences Inc
NASDAQ:ALPN
Wall Street
Price Targets
ALPN Price Targets Summary
Alpine Immune Sciences Inc
According to Wall Street analysts, the average 1-year price target for
ALPN
is 63.24 USD
with a low forecast of 44.44 USD and a high forecast of 68.25 USD.
ALPN Last Price Targets
Alpine Immune Sciences Inc
The latest public price target was made on Apr 11, 2024 by
Robert Driscoll
from
Wedbush
,
who expects
ALPN
stock to
rise by 1%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Robert Driscoll
Wedbush
|
65
USD
Upside 1% |
2 weeks ago
Apr 11, 2024
|
Wedbush downgrades Alpine Immune, sees takeout deal closing
TheFly
|
Michael Ulz
Morgan Stanley
|
65
USD
Upside 1% |
2 weeks ago
Apr 11, 2024
|
Alpine Immune Sciences downgraded to Equal Weight at Morgan Stanley
TheFly
|
Vamil Divan
Guggenheim
|
55
USD
Downside 15% |
2 weeks ago
Apr 9, 2024
|
Alpine Immune Sciences initiated with a Buy at Guggenheim
TheFly
|
Andy Chen
Wolfe Research
|
46
USD
Downside 29% |
1 month ago
Mar 20, 2024
|
Alpine Immune Sciences (ALPN) PT Raised to $46 at Wolfe Research
StreetInsider
|
Justin Kim
Oppenheimer
|
44
USD
Downside 32% |
1 month ago
Mar 19, 2024
|
Alpine Immune Sciences (ALPN) PT Raised to $44 at Oppenheimer
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALPN's stock price target?
Price Target
63.24
USD
According to Wall Street analysts, the average 1-year price target for
ALPN
is 63.24 USD
with a low forecast of 44.44 USD and a high forecast of 68.25 USD.
What is Alpine Immune Sciences Inc's Revenue forecast?
Projected CAGR
-44%
For the last 8 years the
compound annual growth rate for
Alpine Immune Sciences Inc's revenue is
82%.
The projected
CAGR
for the next 3 years is
-44%.
You don't have any saved screeners yet
